| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.098 | 0.7 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.054 | 0.8 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |